Respectfully, I strongly disagree. I too have been invested in biotechs for a few decades, and have seen (hindsight is Amazing) times when pulling money off the table is prudent (June 30, 2020 might fit this scenario).

But, LL is like no molecule I have ever come across. Sure, there will be spikes and pullbacks but bigger spikes will follow the pullbacks for quite some time- this is a multi-disease state platform drug; that can’t be understated.

I have always told friends, “put in whatever $ you are willing to lose” which distances me from the time this has taken and price drops we have endured but I’ll be damned if I’m going to sell because it spikes. I’ll sell to make big purchases in the things we all dream about, but, knowing what I know about how LL performs by blocking CCR5, I’ll keep my money in CYDY or any acquiring company until we have 10 or more indications- and that’s only if I need it. It’ll be a money-machine then.

But everyone has their own threshold for risk tolerance and the degree of need for money varies as well. I’m just happy to let it ride when the spikes come. There certainly won’t just be one. GLTAL